MAPK1 and breast cancer: To determine the effects of ChPL on MAPK signaling in breast cancer cells, MDA-MB-468 and MCF-7 cells were treated with ChPL and Western blot analysis was performed to examine the effects of ChPL on levels of phosphorylated MEK and ERK in breast cancer cells.